Dr. Kate Onorato Bedrin, MD

Dr. Bedrin practices at Virginia Mason Medical Center - HOPD in Seattle, Washington.

Dr. Bedrin's NPI, 1457883852, was assigned on April 3, 2017. Dr. Bedrin holds Washington license MD.MD.61418097.

Dr. Bedrin's primary practice is Virginia Mason Medical Center - HOPD, at 1100 9th Ave, Seattle, WA 98101.

Dr. Bedrin's primary practice is Virginia Mason Medical Center - HOPD in Seattle, Washington. Dr. Bedrin is also affiliated with Virginia Mason Medical Center. The medical group on file is Virginia Mason Medical Center. Dmand AI also links Dr. Bedrin to 1 more imaging center, named with a free account. Dr. Bedrin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bedrin practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Bedrin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Bedrin is licensed in Washington.

CMS data shows 494 Medicare services from Dr. Bedrin across 8 procedure codes in 2024, for 150 Medicare patients. Medicare paid $36,215 for them. Every service was in an office.

CMS counts 150 Medicare patients who saw Dr. Bedrin in 2024. The largest group is 65 to 74, with 52 patients. 69% of them have high blood pressure, and 62% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bedrin's median patient age at 61, with 73% women.

In 2024, Dr. Bedrin wrote 854 Medicare Part D claims for 167 patients. 82% of them were for generic drugs. CMS names the drug for 680 of them, across 22 drugs with 11 or more claims each, at $150,985 in total drug cost. In 2023, CMS named 24 claims across 2 drugs.

Dr. Bedrin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bedrin as offering telehealth.

Dmand AI links 5 papers to Dr. Bedrin, published from 2020 to 2024. The most frequent topics are Calcitonin Gene-Related Peptide, Calcitonin Gene-Related Peptide Receptor Antagonists and Migraine Disorders. Dr. Bedrin's most frequent co-authors are Jessica Ailani, MD, Carrie Oakley Dougherty, MD and Amanda Grace Tinsley, MD.

CMS Open Payments shows 48 general payments to Dr. Bedrin from 10 drug and device companies from 2020 to 2023. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $441.